An inhibitor of histone deacetylase 6 activity, ACY-1215, reduces cAMP and cyst growth in polycystic kidney disease

Por Yanda, Murali K., Liu, Qiangni, Cebotaru, Liudmila
Publicado no Am J Physiol Renal Physiol (2017)

A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector

Por Yanda, Murali K., Liu, Qiangni, Cebotaru, Liudmila
Publicado no J Biol Chem (2018)

Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca(2+) in knock-out mouse models of polycystic kidney disease

Por Yanda, Murali K., Liu, Qiangni, Cebotaru, Valeriu, Guggino, William B., Cebotaru, Liudmila
Publicado no J Biol Chem (2017)

Role of calcium in adult onset polycystic kidney disease

Por Yanda, Murali K., Liu, Qiangni, Cebotaru, Valeriu, Guggino, William B., Cebotaru, Liudmila
Publicado no Cell Signal (2018)

Rescue of CFTR NBD2 mutants N1303K and S1235R is influenced by the functioning of the autophagosome

Por Liu, Qiangni, Sabirzhanova, Inna, Yanda, Murali K., Bergbower, Emily A.S., Boinot, Clément, Guggino, William B., Cebotaru, Liudmila
Publicado no J Cyst Fibros (2018)

Rituximab inhibits Kv1.3 channels in human B lymphoma cells via activation of FcγRIIB receptors

Por Wang, Li-Hua, Wang, Ning, Lu, Xiao-Yu, Liu, Bing-Chen, Yanda, Murali K., Song, John Z., Dai, Helena M., Sun, Yu-Liang, Bao, Hui-Fang, Eaton, Douglas C., Ma, He-Ping
Publicado em 2011